Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Perrigo Co's Enterprise Value is $7,560 Mil.
Perrigo Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $166 Mil. Therefore, Perrigo Co's EV-to-EBIT ratio for today is 45.65.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Perrigo Co's Enterprise Value is $7,560 Mil.
Perrigo Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $525 Mil. Therefore, Perrigo Co's EV-to-EBITDA ratio for today is 14.40.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Perrigo Co's Enterprise Value is $7,560 Mil.
Perrigo Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $4,656 Mil. Therefore, Perrigo Co's EV-to-Revenue ratio for today is 1.62.
Perrigo Co Enterprise Value Historical Data
The historical data trend for Perrigo Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Perrigo Co's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Enterprise Value falls into.
Perrigo Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Perrigo Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co (NYSE:PRGO) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Perrigo Co's current Enterprise Value is $7,560 Mil.
Perrigo Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $166 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Perrigo Co's current Enterprise Value is $7,560 Mil.
Perrigo Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $525 Mil.
Perrigo Co's current Enterprise Value is $7,560 Mil.
Perrigo Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4,656 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Perrigo Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRGO has been successfully added to your 